2026 · 3rd Quarter (July 1 - Sep 30)

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS

Filed by JIM MASSIE & PARTNERS, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: JIM MASSIE & PARTNERS, LLC
Client: COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS
Filing UUID: ce279428-a57e-49e9-9b06-ca2751ced4b4
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

ENG · Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025 H.R. 5334, Lindsey O. Graham Sanctioning Russia Act of 2026 H.R.2913, Ukraine Support Act

Literal federal measure citations: S.1241, H.R. 5334, H.R.2913

TRD · Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.